Health Tech Weekly guest host Chris Montera, the Geekymedic, checks in at the InBody booth at the International CES conference’s digital health pavilion. Obesity is a health issue facing much of the industrialized world. Having a way to monitor, define problem areas, and create targeted goals for weight loss is an important part of treating this epidemic. InBody systems from BioSpace is leading the way in body composition monitoring.
The InBody system and parent company Biospace has made the terms “body composition” and “body fat” popular in helping to define the source of the problem. The prevention of obesity hinges on reduction and control of body fat. The InBody test is a commonly given body composition analysis that is increasing in popularity. Understanding and knowledge of the underlying problem gives the person power to devise a targeted weight loss and fitness program.
The InBody system, made by Biospace uses a unique 8-point tactile electrode method to determine body composition. It has received FDA approval for use in the United States. The accuracy and quality of the device’s findings is key to developing a patient fitness profile that can be used to create a personalized program for improving body fat and wellness.
Follow all the digital health coverage from CES 2014 here at the Tech Podcast Network at over at theHealth Tech Weekly podcast with Jamie Davis, the Podmedic.